Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
Clinical trial NCT04631835 · UNKNOWN
Trial details
- NCT number
- NCT04631835
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2023-04-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.